Skip to main content
Equibles

BRIDGEWAY CAPITAL MANAGEMENT, LLC

Position in SGMT — Sagimet Biosciences Inc.

CIK 1107261 HOUSTON, TX
Back to SGMT Full portfolio

Position in SGMT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,712,511
+$146,887 QoQ
Shares Held
221,541
-26.1% QoQ
Ownership
0.356%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#38
of 122 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SGMT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $87,985,615 across 108 Biotechnology names. SGMT ranks #9 (1.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 GLUE
Monte Rosa Therapeutics, Inc.
 552,566 $13,372,097
2 INVA
Innoviva, Inc.
 350,253 $7,954,245
3 PBYI
Puma Biotechnology, Inc.
 791,616 $6,420,005
4 RIGL
Rigel Pharmaceuticals Inc
 124,184 $4,858,078
5 EXEL
Exelixis, Inc.
 66,100 $3,596,501
6 CRMD
CorMedix Inc.
 434,132 $3,407,936
7 KROS
Keros Therapeutics, Inc.
 265,017 $2,835,681
8 PTCT
Ptc Therapeutics, Inc.
 22,000 $1,794,540

All Filings in SGMT

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,712,511 221,541
2026-03-31 $1,565,624 299,641
2025-12-31 $1,773,874 299,641
2025-09-30 $2,055,537 299,641
2025-06-30 $3,145,848 412,841
2025-03-31 $405,870 124,500
2024-12-31 $1,008,450 224,100
2024-09-30 $383,091 138,300
2024-06-30 $153,900 45,000
2024-03-31 $243,900 45,000
2023-12-31 $243,900 45,000